Treatment of hypertension and other abnormal risk factors should be initiated early in life before severe atherosclerosis develops.
Is it true that treatment of hypertension and other abnormal risk factors should be initiated early in life before severe atherosclerosis develops?
Yes. The retrieved literature strongly supports initiating cardiovascular risk factor treatment and monitoring early in life, as subclinical vascular changes and risk factor accumulation frequently begin in childhood, adolescence, or young adulthood.
Verdict: SUPPORTED · 8 sources for, 0 against · Last checked
The provided papers consistently demonstrate that cardiovascular risk factors, endothelial dysfunction, and subclinical atherosclerosis frequently originate or show early manifestations in childhood, adolescence, or young adulthood. Multiple reviews and empirical studies emphasize the necessity of early screening and preventive cardiology to alter the long-term trajectory of cardiovascular disease. Because no papers refute the premise and multiple sources substantiate the value of early-life risk management, the claim is supported.
Get citation
Jackson, D. B., Testa, A., Woodward, K. P., Qureshi, F., Ganson, K., & Nagata, J. M. (2022). Adverse Childhood Experiences and Cardiovascular Risk among Young Adults: Findings from the 2019 Behavioral Risk Factor Surveillance System. doi.org. https://doi.org/10.3390/ijerph191811710
See more details
Get citation
Y, A., M, G., JE, R. v. L., LJ, S., & CN, B. M. (2026). Cardiovascular disease in women: traditional and sex-specific risk factors.. doi.org. https://doi.org/10.1093/eurheartj/ehaf1001
Get citation
Grabitz, C., Sprung, K. M., Amagliani, L., Memaran, N., Schmidt, B., Tegtbur, U., Born, J. v. d., Kerling, A., & Melk, A. (2023). Cardiovascular health and potential cardiovascular risk factors in young athletes. doi.org. https://doi.org/10.3389/fcvm.2023.1081675
Get citation
S, A., J, B., L, G., A, S., S, G., JA, A., J, D. L., & AB, R. (2026). The Natural History of Prediabetes and Cardiovascular Disease in the Pediatric Population.. doi.org. https://doi.org/10.3390/biomedicines14010198
Get citation
A, T., J, H., A, O., J, S., JA, D., & FF, C. (2026). Carotid Intima-Media Thickness as a Marker of Subclinical Atherosclerosis in Adolescents With Severe Haemophilia.. doi.org. https://doi.org/10.1111/hae.70187
Get citation
M, D., CK, C., CH, S., & KK, P. (2025). Frontiers in subclinical atherosclerosis and the latest in early life preventive cardiology.. doi.org. https://doi.org/10.4103/singaporemedj.smj-2024-169
Get citation
Hou, C., Zhang, N., Liu, C., & Gao, W. (2025). Global burden and risk factors of childhood cardiovascular disease (1990–2021). doi.org. https://doi.org/10.3389/fpubh.2025.1543044
Get citation
A, S., I, V., & R, B. (2026). The Silent Vascular Shift: Endothelial Dysfunction and Cardiovascular Risk in Menopausal Women.. doi.org. https://doi.org/10.2174/011871529x448903260820091109
What does the evidence say?
The provided papers consistently demonstrate that cardiovascular risk factors, endothelial dysfunction, and subclinical atherosclerosis frequently originate or show early manifestations in childhood, adolescence, or young adulthood. Multiple reviews and empirical studies emphasize the necessity of early screening and preventive cardiology to alter the long-term trajectory of cardiovascular disease. Because no papers refute the premise and multiple sources substantiate the value of early-life risk management, the claim is supported.
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work